oxazoles has been researched along with HIV Coinfection in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| De Los Rios, J; Diacon, AH; Dooley, KE; Karlsson, MO; Maartens, G; Shenje, J; Svensson, EM; Tanneau, L; Upton, CM; Wiesner, L | 1 |
| Aladinskiy, VA; Ivanenkov, YA; Ivashchenko, AA; Ivashchenko, AV; Karapetian, RN; Koryakova, AG; Kravchenko, DV; Mitkin, OD; Savchuk, NP | 1 |
| Avaliani, Z; Ferlazzo, G; Hayrapetyan, A; Hewison, C; Jonckheere, S; Khaidarkhanova, Z; Lachenal, N; Mohr, E; Sinha, A; Skrahina, A; Vambe, D; Varaine, F; Vasilyeva, I | 1 |
| Cox, H; De Avezedo, V; Egazaryan, L; Ferlazzo, G; Furin, J; Hewison, C; Hughes, J; Isaakidis, P; Jonckheere, S; Kalon, S; Khachatryan, N; Laxmeshwar, C; Mohr, E; Shroufi, A | 1 |
| Gupta, R; Hafkin, J; Hittel, N; Martin, A | 1 |
| Choong, M; Fairlie, DP; Harrich, D; Harris, J; Li, D; Lor, M; Poulsen, SA; Rawle, DJ; Reid, RC; Tachedjian, G; Wang, L; Wu, Z | 1 |
| Centis, R; D'Ambrosio, L; Migliori, GB; Pontali, E; Sotgiu, G; Spanevello, A | 1 |
| Garcia-Prats, AJ; Hesseling, AC; Schaaf, HS; Thee, S; van der Laan, L | 1 |
| Muller, WJ | 1 |
| Akkerman, OW; Alffenaar, JC; Anthony, RM; Cobelens, FG; Grobusch, MP; Heysell, S; Tiberi, S; Van Soolingen, D | 1 |
| Buscombe, JR; Johnson, MA; Thomson, AP; Tormey, VJ; Webster, AD | 1 |
4 review(s) available for oxazoles and HIV Coinfection
| Article | Year |
|---|---|
Management of drug resistantTB in patients with HIV co-infection.
Topics: Antitubercular Agents; Coinfection; Diarylquinolines; Disease Management; Extensively Drug-Resistant Tuberculosis; HIV Infections; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; World Health Organization | 2015 |
Adverse effects of oral second-line antituberculosis drugs in children.
Topics: Age Factors; Antitubercular Agents; Child; Diarylquinolines; Dose-Response Relationship, Drug; HIV Infections; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant | 2016 |
Treatment of perinatal viral infections to improve neurologic outcomes.
Topics: Acyclovir; Antiviral Agents; Brain; Cognition; Cognition Disorders; Encephalitis, Herpes Simplex; Enterovirus Infections; Female; Ganciclovir; HIV Infections; Humans; Infant, Newborn; Nervous System Diseases; Oxadiazoles; Oxazoles; Pregnancy; Valganciclovir; Virus Diseases | 2017 |
Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers.
Topics: Antitubercular Agents; Biomarkers; Clinical Trials as Topic; Coinfection; Diarylquinolines; Extensively Drug-Resistant Tuberculosis; HIV Infections; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Practice Guidelines as Topic; Precision Medicine | 2017 |
7 other study(ies) available for oxazoles and HIV Coinfection
| Article | Year |
|---|---|
Population Pharmacokinetics of Delamanid and its Main Metabolite DM-6705 in Drug-Resistant Tuberculosis Patients Receiving Delamanid Alone or Coadministered with Bedaquiline.
Topics: Adult; Albumins; Antitubercular Agents; Diarylquinolines; HIV Infections; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant | 2022 |
Synthesis, biological evaluation and in silico modeling of novel integrase strand transfer inhibitors (INSTIs).
Topics: Animals; Computer Simulation; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Male; Models, Molecular; Molecular Docking Simulation; Mutation; Oxazoles; Pyridones; Rats; Rats, Sprague-Dawley; Virus Replication | 2020 |
Six-Month Response to Delamanid Treatment in MDR TB Patients.
Topics: Adolescent; Antitubercular Agents; Female; Hepatitis C; HIV Infections; Humans; Male; Nitroimidazoles; Oxazoles; Retrospective Studies; Tuberculosis, Multidrug-Resistant | 2017 |
Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study.
Topics: Adult; Antitubercular Agents; Armenia; Arrhythmias, Cardiac; Cohort Studies; Diarylquinolines; Drug Therapy, Combination; HIV Infections; Humans; India; Nitroimidazoles; Oxazoles; Retrospective Studies; South Africa; Tuberculosis, Multidrug-Resistant | 2018 |
Compassionate use of delamanid in combination with bedaquiline for the treatment of multidrug-resistant tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Compassionate Use Trials; Diarylquinolines; Drug Therapy, Combination; Female; HIV Infections; Humans; Internationality; Male; Middle Aged; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Young Adult | 2019 |
Oxazole-Benzenesulfonamide Derivatives Inhibit HIV-1 Reverse Transcriptase Interaction with Cellular eEF1A and Reduce Viral Replication.
Topics: Anti-HIV Agents; Benzenesulfonamides; HEK293 Cells; HeLa Cells; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Oxazoles; Peptide Elongation Factor 1; Reverse Transcriptase Inhibitors; Reverse Transcription; Sulfonamides; Virus Replication | 2019 |
SPECT scans for monitoring response to pleconaril therapy in chronic enteroviral meningoencephalitis.
Topics: Adolescent; Adult; Antiviral Agents; Common Variable Immunodeficiency; Enterovirus; Enterovirus Infections; Female; HIV Infections; Humans; Immunocompromised Host; Male; Meningoencephalitis; Oxadiazoles; Oxazoles; Tomography, Emission-Computed, Single-Photon | 2003 |